These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20032146)

  • 1. Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice.
    Hines CD; Yu H; Shimakawa A; McKenzie CA; Warner TF; Brittain JH; Reeder SB
    Radiology; 2010 Jan; 254(1):119-28. PubMed ID: 20032146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy.
    Meisamy S; Hines CD; Hamilton G; Sirlin CB; McKenzie CA; Yu H; Brittain JH; Reeder SB
    Radiology; 2011 Mar; 258(3):767-75. PubMed ID: 21248233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of MRI biomarkers of hepatic steatosis in the presence of iron overload in the ob/ob mouse.
    Hines CD; Agni R; Roen C; Rowland I; Hernando D; Bultman E; Horng D; Yu H; Shimakawa A; Brittain JH; Reeder SB
    J Magn Reson Imaging; 2012 Apr; 35(4):844-51. PubMed ID: 22127834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling.
    Reeder SB; Robson PM; Yu H; Shimakawa A; Hines CD; McKenzie CA; Brittain JH
    J Magn Reson Imaging; 2009 Jun; 29(6):1332-9. PubMed ID: 19472390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of intrahepatic lipids using fat-selective imaging with spectral-spatial excitation and in-/opposed-phase gradient echo imaging techniques within a study population of extremely obese patients: feasibility on a short, wide-bore MR scanner.
    Springer F; Machann J; Schwenzer NF; Ballweg V; Würslin C; Schneider JH; Fritsche A; Claussen CD; Schick F
    Invest Radiol; 2010 Aug; 45(8):484-90. PubMed ID: 20479651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results.
    Kühn JP; Hernando D; Muñoz del Rio A; Evert M; Kannengiesser S; Völzke H; Mensel B; Puls R; Hosten N; Reeder SB
    Radiology; 2012 Oct; 265(1):133-42. PubMed ID: 22923718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of hepatic steatosis with dual-energy computed tomography: comparison with tissue reference standards and quantitative magnetic resonance imaging in the ob/ob mouse.
    Artz NS; Hines CD; Brunner ST; Agni RM; Kühn JP; Roldan-Alzate A; Chen GH; Reeder SB
    Invest Radiol; 2012 Oct; 47(10):603-10. PubMed ID: 22836309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
    Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
    Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T.
    Yokoo T; Shiehmorteza M; Hamilton G; Wolfson T; Schroeder ME; Middleton MS; Bydder M; Gamst AC; Kono Y; Kuo A; Patton HM; Horgan S; Lavine JE; Schwimmer JB; Sirlin CB
    Radiology; 2011 Mar; 258(3):749-59. PubMed ID: 21212366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis.
    Kühn JP; Hernando D; Mensel B; Krüger PC; Ittermann T; Mayerle J; Hosten N; Reeder SB
    J Magn Reson Imaging; 2014 Jun; 39(6):1494-501. PubMed ID: 24123655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological characterization of hepatic steatosis and Monte Carlo modeling of MRI signal for accurate quantification of fat fraction and relaxivity.
    Shrestha U; van der Merwe M; Kumar N; Jacobs E; Satapathy SK; Morin C; Tipirneni-Sajja A
    NMR Biomed; 2021 Jun; 34(6):e4489. PubMed ID: 33586261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques.
    Schwenzer NF; Machann J; Martirosian P; Stefan N; Schraml C; Fritsche A; Claussen CD; Schick F
    Invest Radiol; 2008 May; 43(5):330-7. PubMed ID: 18424954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI.
    França M; Alberich-Bayarri Á; Martí-Bonmatí L; Oliveira P; Costa FE; Porto G; Vizcaíno JR; Gonzalez JS; Ribeiro E; Oliveira J; Pessegueiro Miranda H
    Abdom Radiol (NY); 2017 May; 42(5):1434-1443. PubMed ID: 28110367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis.
    Hines CD; Frydrychowicz A; Hamilton G; Tudorascu DL; Vigen KK; Yu H; McKenzie CA; Sirlin CB; Brittain JH; Reeder SB
    J Magn Reson Imaging; 2011 Apr; 33(4):873-81. PubMed ID: 21448952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive determination of hepatic steatosis by acoustic structure quantification from ultrasound echo amplitude.
    Kuroda H; Kakisaka K; Kamiyama N; Oikawa T; Onodera M; Sawara K; Oikawa K; Endo R; Takikawa Y; Suzuki K
    World J Gastroenterol; 2012 Aug; 18(29):3889-95. PubMed ID: 22876042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy.
    Guiu B; Petit JM; Loffroy R; Ben Salem D; Aho S; Masson D; Hillon P; Krause D; Cercueil JP
    Radiology; 2009 Jan; 250(1):95-102. PubMed ID: 19092092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
    Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
    Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease.
    Lee SS; Lee Y; Kim N; Kim SW; Byun JH; Park SH; Lee MG; Ha HK
    J Magn Reson Imaging; 2011 Jun; 33(6):1390-8. PubMed ID: 21591008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of goose liver fat measurement by QCT and CSE-MRI with biochemical extraction and pathology as reference.
    Xu L; Duanmu Y; Blake GM; Zhang C; Zhang Y; Brown K; Wang X; Wang P; Zhou X; Zhang M; Wang C; Guo Z; Guglielmi G; Cheng X
    Eur Radiol; 2018 May; 28(5):2003-2012. PubMed ID: 29238866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.